Cancer Genetics amends IPO again

Cancer Genetics Inc. (Rutherford, N.J.) again amended its IPO, lowering to 600,000 the number of shares it plans to sell at $10-$12. An $11 price would raise $6.6 million and value the cancer diagnost...